Leaning Toward a Better Understanding of CRT in Women

Cardiac resynchronization-defibrillation therapy (CRT-D) is now a well-established treatment for patients with symptomatic heart failure unresponsive to optimized pharmacological therapy, including an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker and a beta-adrenergic block...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2014-09, Vol.64 (9), p.895-897
1. Verfasser: Dec, G. William, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cardiac resynchronization-defibrillation therapy (CRT-D) is now a well-established treatment for patients with symptomatic heart failure unresponsive to optimized pharmacological therapy, including an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker and a beta-adrenergic blocker (1). [...]as with any observational study, there is a possibility of unmeasured, confounding variables, including noncardiac comorbidities.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.06.1161